Candida Glabrata Lymphadenitis Following Infliximab Therapy for Inflammatory Bowel Disease in a Patient With Chronic Granulomatous Disease: Case Report and Literature Review
Chronic granulomatous disease (CGD) is an inborn error of immunity caused by inactivating genetic mutations in any one of the components of the phagocyte nicotinamide adenine dinucleotide phosphate (NADPH) oxidase complex. Phagocytic cell reactive oxygen species generation is impaired in the absence...
Saved in:
Main Authors: | Heather Kristin Lehman (Author), Rahool Davé (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Infliximab in inflammatory bowel disease
by: Konstantinos Papamichael, et al.
Published: (2019) -
Beware of the persistent abscess: Chronic granulomatous disease presenting with suppurative lymphadenitis
by: C. Pardy, et al.
Published: (2016) -
USE OF INFLIXIMAB IN THE CASE OF INFLAMMATORY BOWEL DISEASE IN CHILDREN
by: N.E. Shchigoleva, et al.
Published: (2010) -
USE OF INFLIXIMAB IN THE CASE OF INFLAMMATORY BOWEL DISEASE IN CHILDREN
by: N.E. Shchigoleva, et al.
Published: (2010) -
Infusion Reactions to Infliximab in Pediatric Patients with Inflammatory Bowel Disease
by: Rajmohan Dharmaraj, et al.
Published: (2024)